Welcome to the International Oncology Cancer Institute (IOCI) in Mumbai, a beacon of
excellence in the realm of oncology care. With over a decade of service, our Mumbai hospital,
nestled within Hiranandani Hospital Powai, has been serving the community as a prominent
cancer care institution. Recognized as one of the finest cancer care hospitals in Mumbai, IOCI
Mumbai caters to the entire central belt and Thane region.
Acknowledging the necessity for a comprehensive cancer institute armed with the latest
technologies and premier medical care, we have established a new comprehensive cancer care
hospital in Mumbai. Boasting a legacy spanning more than 15 years, our commitment to
providing the utmost quality in cancer care remains unwavering, driven by the latest
breakthroughs in diagnostic and therapeutic research. Our paramount objective revolves
around empowering you to stand resolute in your battle against cancer.
Within IOCI India (International Oncology Cancer Institute), our central focus orbits around
you—the patient. Our team of adept oncologists is wholeheartedly devoted to crafting tailored
treatment plans catered to a diverse array of cancer types. By fostering seamless collaboration
within a multidisciplinary framework, we extend comprehensive care inclusive of
chemotherapy, targeted therapy, and immunotherapy—each meticulously guided by genetic
insights. Our network embraces seven state-of-the-art hospitals, underscoring our commitment
to compassionate care and pioneering innovation that remains unmatched.
Our facilities proudly showcase the latest in medical technologies, including a PET Scan,
comprehensive operating theaters, highly equipped diagnostics, dedicated outpatient
consultations, and advanced chemotherapy and radiation setups. This unwavering commitment
to medical progress ensures flexible treatment avenues and advanced imaging, all while placing
your safety at the forefront.
Rest assured, a global assembly of experts seamlessly melding compassion and expertise stands
ready to serve you. Operating in unison, we are steadfast in our commitment to delivering
transformative cancer care that sets novel benchmarks within the field.